Article

Refractive IOL shows excellent distance, intermediate vision

A second-generation refractive multifocal IOL provides excellent distance and intermediate vision, with distance, intermediate, and near vision improving over time, according to preliminary results of an ongoing multicenter study.

Key Points

George H.H. Beiko, BM, BCh, FRCSC, in private practice at St. Catharines, Ontario, Canada, presented results to date of a prospective study that enrolled 161 patients at 18 centers to assess the quality of vision-and change in vision over time-with bilateral implantation of the hydrophilic acrylic three-piece lens with zonal refractive optics.

All patients undergoing either clear lensectomy or cataract surgery with one of 18 participating surgeons were eligible for inclusion in the study with the exception of those who had conditions that might predispose them to decreased vision or in whom the lens would not be anticipated to give good results, Dr. Beiko said. Such conditions include significant dry eye, corneal scarring, mild to moderate myopia, pupil diameter of less than 2.5 mm, a monofocal implant in the first eye, and significant astigmatism, he added.

Dr. Beiko reported data on 106 patients who had completed the 6-week follow-up and 98 who had completed the 6-month follow-up. "We are continuing to gather information on the patients," he said.

Mean patient age was 62 years. At the 6-week follow-up, 12.7% of the 106 patients were aged 50 or fewer years, 20.6% were aged 51 to 60 years, and 66.7% were aged at least 61 years. At the 6-month follow-up, 10.2% of the 98 patients were aged up to 50 years, 20.4% were aged 51 to 60 years, and 69.4% were aged at least 61 years.

Dr. Beiko said the study's gender distribution reflects that seen in his cataract practice: 55% of the 106 patients at the 6-week follow-up were female, as were 59.5% of the 98 patients at the 6-month follow-up.

Vision improvement

"The postop refraction was targeted at emmetropia to +0.50 D so as to allow the patient good distance vision for driving," Dr. Beiko said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.